Evolution of Practice Patterns for the Treatment of Fungal Keratitis.
作者信息
Oldenburg Catherine E, Prajna N Venkatesh, Amza Abdou, Loh Allison, Acharya Nisha R, Mannis Mark J, Lietman Thomas M
机构信息
Francis I. Proctor Foundation, University of California, San Francisco
Department of Ophthalmology, University of California, San Francisco
出版信息
JAMA Ophthalmol. 2017 Dec 1;135(12):1448-1449. doi: 10.1001/jamaophthalmol.2017.4763.
Abstract
摘要
相似文献
1
Evolution of Practice Patterns for the Treatment of Fungal Keratitis.
JAMA Ophthalmol. 2017 Dec 1;135(12):1448-1449. doi: 10.1001/jamaophthalmol.2017.4763.
2
Association of pretreatment with antifungal medication and fungal resistance in the mycotic ulcer treatment trial I.
JAMA Ophthalmol. 2015 Oct;133(10):1210-1. doi: 10.1001/jamaophthalmol.2015.2040.
3
Practice patterns in the management of fungal and acanthamoeba keratitis: a five-continent survey.
Acta Ophthalmol. 2021 Nov;99(7):e1250-e1251. doi: 10.1111/aos.14747. Epub 2021 Jun 6.
4
Identification and Characterization of Fusarium proliferatum, a New Species of Fungi that Cause Fungal Keratitis.
Sci Rep. 2018 Mar 20;8(1):4859. doi: 10.1038/s41598-018-23255-z.
5
Study of Pathogens of Fungal Keratitis and the Sensitivity of Pathogenic Fungi to Therapeutic Agents with the Disk Diffusion Method.
Curr Eye Res. 2015;40(11):1095-101. doi: 10.3109/02713683.2015.1056802. Epub 2015 Aug 13.
6
Riboflavin/ultravoilet light-mediated crosslinking for fungal keratitis.
Br J Ophthalmol. 2013 May;97(5):669-71. doi: 10.1136/bjophthalmol-2012-302518. Epub 2013 Jan 26.
7
Therapeutic response time of topical voriconazole 1% and intrastromal voriconazole 0.05% versus topical natamycin 5% monotherapy in Fusarium keratitis in rabbit.
Mycoses. 2020 Oct;63(10):1128-1132. doi: 10.1111/myc.13160. Epub 2020 Sep 4.
8
Fungal Keratitis: Epidemiology, Rapid Detection, and Antifungal Susceptibilities of and Isolates from Corneal Scrapings.
Biomed Res Int. 2019 Jan 20;2019:6395840. doi: 10.1155/2019/6395840. eCollection 2019.
9
Natamycin and voriconazole in Fusarium and Aspergillus keratitis: subgroup analysis of a randomised controlled trial.
Br J Ophthalmol. 2012 Nov;96(11):1440-1. doi: 10.1136/bjophthalmol-2012-301825. Epub 2012 Aug 21.
10
Expert prior elicitation and Bayesian analysis of the Mycotic Ulcer Treatment Trial I.
Invest Ophthalmol Vis Sci. 2013 Jun 14;54(6):4167-73. doi: 10.1167/iovs.13-11716.
引用本文的文献
1
[Fungal keratitis in Germany : Diagnostics, conservative and microsurgical treatment].
Ophthalmologie. 2025 Jul 24. doi: 10.1007/s00347-025-02274-y.
2
Overview of Mycotic Keratitis.
Cornea. 2024 Sep 1;43(9):1065-1071. doi: 10.1097/ICO.0000000000003559. Epub 2024 May 8.
本文引用的文献
1
Re-appraisal of topical 1% voriconazole and 5% natamycin in the treatment of fungal keratitis in a randomised trial.
Br J Ophthalmol. 2015 Sep;99(9):1190-5. doi: 10.1136/bjophthalmol-2014-306485. Epub 2015 Mar 4.
2
The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole.
JAMA Ophthalmol. 2013 Apr;131(4):422-9. doi: 10.1001/jamaophthalmol.2013.1497.
3
Natamycin and voriconazole in Fusarium and Aspergillus keratitis: subgroup analysis of a randomised controlled trial.
Br J Ophthalmol. 2012 Nov;96(11):1440-1. doi: 10.1136/bjophthalmol-2012-301825. Epub 2012 Aug 21.
4
Organism, minimum inhibitory concentration, and outcome in a fungal corneal ulcer clinical trial.
Cornea. 2012 Jun;31(6):662-7. doi: 10.1097/ICO.0b013e31823f8ae0.
5
Voriconazole versus natamycin as primary treatment in fungal corneal ulcers.
Clin Exp Ophthalmol. 2011 Jul;39(5):434-40. doi: 10.1111/j.1442-9071.2010.02473.x. Epub 2011 Jun 28.
6
Practice patterns in the management of fungal corneal ulcers.
Cornea. 2009 Sep;28(8):856-9. doi: 10.1097/ICO.0b013e318199fa77.
Zotero 插件